SCHEMBL3628522

SCHEMBL3628522

CON=C1C(=O)OCc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.56
MAOB P27338 4/20 0.56
ALDH1A1 P00352 7/20 0.46
MAPT P10636 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 3/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
ALOX12 P18054 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HSD17B10 Q99714 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
TYMS P04818 1/20 0.45
CYP3A4 P08684 1/20 0.40
LMNA P02545 2/20 0.37
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29765453 1.00 MAOA (0.56) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL3628521 1.00 MAOA (0.56) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL28050278 1.00 MAOA (0.56) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL3622575 0.79 MAOA (0.64) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL3622578 0.79 MAOA (0.64) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL11372112 0.79 MAOA (0.48) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL13167844 0.74 MAOA (0.45) MAOAALDH1A1MAPTKDM4EHPGD
Ethane SCHEMBL28050141 0.74 MAOA (0.91) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL6353583 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTKDM4E
SCHEMBL6903786 0.73 MAOA (1.00) MAOAMAOBALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685313-B Preparation method of trifloxystrobin 江西天宇化工有限公司 2024-04-05 CN claimed
CN-116462650-A Preparation method of 3-ketone-4- (methoxyimino) isochroman 河北诚信集团有限公司 2023-07-21 CN claimed
CN-114685313-A Preparation method of trifloxystrobin 南通泰禾化工股份有限公司 2022-07-01 CN claimed
CN-114685313-B Preparation method of trifloxystrobin 江西天宇化工有限公司 2024-04-05 CN disclosed
CN-114685313-B Preparation method of trifloxystrobin 江西天宇化工有限公司 2024-04-05 CN disclosed
CN-116462650-A Preparation method of 3-ketone-4- (methoxyimino) isochroman 河北诚信集团有限公司 2023-07-21 CN disclosed
CN-114685313-A Preparation method of trifloxystrobin 南通泰禾化工股份有限公司 2022-07-01 CN disclosed
CN-114685313-A Preparation method of trifloxystrobin 南通泰禾化工股份有限公司 2022-07-01 CN disclosed
CN-105294490-A Trifloxystrobin synthesizing method JIANGSU CHANGQING AGROCHEMICAL CO LTD 2016-02-03 CN disclosed
EP-2393775-B1 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2014-06-25 EP disclosed
US-8575366-B2 Method for producing 2-halogenomethylphenyl acetic acid derivatives BASF SE (DE) 2013-11-05 US disclosed
EP-2393775-A2 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2011-12-14 EP disclosed
US-20110295022-A1 Method for producing 2-halogenomethylphenyl acetic acid derivatives BASE SE (DE) 2011-12-01 US disclosed
WO-2010089267-A2 METHOD FOR PRODUCING 2-HALOGENOMETHYLPHENYL ACETIC ACID DERIVATIVES BASF SE (DE) 2010-08-12 WO disclosed
US-6465457-B1 CONTROLLING PATHOGENS ON PLANTS OR SEEDS ZENECA LIMITED (GB) 2002-10-15 US disclosed
US-5939563-A FUNGICIDES ZENECA LIMITED (GB) 1999-08-17 US disclosed
US-5777162-A Intermediates for the preparation of fungicides ZENECA LIMITED (GB) 1998-07-07 US disclosed
US-5585513-A CHEMICAL INTERMEDIATES ZENECA LIMITED (GB) 1996-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295022-A1 Method for producing 2-halogenomethylphenyl acetic acid derivatives HACL2, AKR7A2, ALAD MAOA 237/4885MAOB 512/4885ALDH1A1 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.